@eric341, yes which big Pharma was RickyH questioning… I’ve gone back & looked through his posts but it is not clear to me. You probably can point it out.
Can’t stand it when posters question the trial size used by pharma companies, along with questioning their research. I find that in this instance size is not important. Big pharma, medium size. Even like a medium size biotech company. Your positivity applies to all.
Good on you Eric for sticking up for pharma companies & the work they do. Mesoblast I’m sure appreciate it too!
We’ll make a MSB shareholder out of you yet!
New Covid 19 treatment, page-290
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $4.942M | 4.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 70659 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 43531 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |